H. Aslan

Cell-mediated gene therapy for bone formation and regeneration.

D. Gazit, Z. Gazit, G. Turgeman, 2002, Current opinion in molecular therapeutics.

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

D. Mevorach, E. Galun, S. Beyth, 2005, Blood.

19 – Mesenchymal Stem Cells

G. Pelled, D. Gazit, Z. Gazit, 2008 .

Molecular targets for tendon neoformation.

G. Pelled, D. Gazit, N. Kimelman-Bleich, 2008, The Journal of clinical investigation.

and induce T-cell unresponsiveness Human mesenchymal stem cells alter antigen-presenting cell maturation

D. Mevorach, S. Beyth, M. Liebergall, 2013 .

Mesenchymal stem cells for bone gene therapy and tissue engineering.

G. Pelled, D. Gazit, Z. Gazit, 2002, Current pharmaceutical design.

Genetically engineered mesenchymal stem cells: applications in spine therapy.

D. Gazit, H. Aslan, D. Sheyn, 2009, Regenerative medicine.

Osteogenic Differentiation of Noncultured Immunoisolated Bone Marrow‐Derived CD105+ Cells

Meir Liebergall, Yoram Zilberman, Dan Gazit, 2006, Stem cells.

Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration.

M. Liebergall, D. Gazit, G. Helm, 2006, Tissue engineering.

Advanced Molecular Profiling in Vivo Detects Novel Function of Dickkopf‐3 in the Regulation of Bone Formation

E. Domany, A. Hoffmann, G. Gross, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Maxillofacial-derived stem cells regenerate critical mandibular bone defect.

D. Gazit, Yair Steinhardt, Y. Zilberman, 2008, Tissue engineering. Part A.